@article{JTD13703,
author = {Charlotte Billiet and Dirk De Ruysscher},
title = {A closer look at the safety and effectiveness of modern PORT in stage III-N2 non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {6},
year = {2017},
keywords = {},
abstract = {We appreciate the interest of Dr. Fiorica in our study (1). The optimal treatment of patients with stage III locally advanced non-small-cell lung cancer (NSCLC) is still debatable. Regarding the high incidences and poor treatment outcomes (2), there is gaining interest in an optimization of the multimodality treatment for these patients.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/13703}
}